Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-27

Clinical Trial Update: Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks [Phase 2]

View source ↗

Summary

A randomized phase II trial is evaluating salvage radiotherapy timing for prostate cancer, comparing 4 weeks versus 2 weeks; the study is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING